This website uses cookies. By using this website, you agree to our use of cookies.

More information can be found in our Privacy policy and Terms of Service.

Explicat Pharma GmbH

Active
Follow company
PDF report

Georg-Knorr-Str. 4, 85662 Hohenbrunn

HRB 156611 Court town München

Beratung und Unterstützung in den Bereichen Arzneimittel, Medizinprodukte, Nahrungsergänzungsmittel und Kosmetik

On 17.09.2026 there was a Credit rating change for Explicat Pharma GmbH.

Get Credit Check

The following information leads to a reassessment of creditworthiness: payment experience, collection reports, insolvency proceedings, fluctuation, executive bodies and environment, contributions in kind and cash, changes in capital.

Check easy, inexpensive and quickly the current credit rating of the company with the Credit check. Additionally, you receive a current credit recommondation in EUR.

Purpose

Provision of services and consultancy services for the life science industry (e.g. cosmetic and food supplement industry, chemical industry); Provision of engineering services in the field of computing, as well as trade in raw materials, consumer and consumer goods, unless a special permit is required.

Owner

This company currently has 4 owners. Get instant, transparent insights – via one-time purchase or free with a premium membership.

Order shareholder report

With Premium

Management

Authorized executives of the company

Managers

Birgit Hettinger, Dr. Weiland-Waibel Andrea

Management transfers

Birgit Hettinger, Dr. Weiland-Waibel Andrea

Complete Management

Person
Authorisation
Period
Andrea, Weiland-Waibel
-
31.03.2005 - until now
Hettinger, Birgit
-
31.03.2005 - until now
All Persons (2)

Unlock exclusive access:

View the full list of former managers at Company Explicat Pharma GmbH by upgrading to a Premium Membership.

Timeline

History

Credit and Financial Report

Make confident credit decisions – based on reliable insights.

Access all relevant information on the creditworthiness, financial position, company structure, and economic environment of your business partners – clearly structured and decision-ready.

The following reports are available through Explicat Pharma GmbH:

Recommended

Credit Light Report

9.50 €

Order now
Example report

Credit Check

12.50 €

Order now
Example report

Economic Report

34.00 €

Order now
Example report

Traffic Light Color / Risk Indicator

Creditworthiness Description

Credit Limit

Rating (International Class, Score, Risk)

Financial Figures (Revenue, Cost, Profit)

Shareholder Structure

Current & Former Management

Liquidity / Debt Ratios

Extended Group Structure

Bank Information

Credit Light Report

  • Traffic Light Color / Risk Indicator
  • Creditworthiness Description

9.50 €

Order now
Example report

Credit Check

  • Traffic Light Color / Risk Indicator
  • Creditworthiness Description
  • Credit Limit

12.50 €

Order now
Example report

Economic Report

  • Traffic Light Color / Risk Indicator
  • Creditworthiness Description
  • Credit Limit
  • Rating (International Class, Score, Risk)
  • Financial Figures (Revenue, Cost, Profit)
  • Shareholder Structure
  • Current & Former Management
  • Liquidity / Debt Ratios
  • Extended Group Structure
  • Bank Information

34.00 €

Order now
Example report

Financial Report

  • Our financial reports provide a comprehensive overview of a company’s economic standing – concise, clear, and decision-focused.
  • Detailed financial indicators: e.g., equity ratio, debt ratio, liquidity, asset structure
  • Multi-year comparison: Trends in key balance sheet items over time
  • Indicator analysis: Evaluation of financial health, risks, and opportunities
  • Strategic assessment: Insights into business model, capital structure, and liquidity position
49.00 €
Order now
Example report

Ultimate Beneficial Owner (UBO) Report

  • Our Ultimate Beneficial Owner (UBO) reports provide transparency into a company’s ownership and control structure – reliable, compliant, and easy to understand.
  • Transparent ownership structures: Identification of shareholders, ownership interests, and controlling persons
  • Structured presentation: Clear visualization of complex ownership chains
  • Security and compliance relevance: Supports KYC, AML, and due diligence processes

39.00 €

Order now
Example report

Note: Information is only included if available in the respective report.

Patents, trade marks and designs

Title
Type of IP right
Date of first publication
Word/figurative mark
Word/figurative mark
02.09.2011
Looking for patent information

Network

Graphical network

Show complete network

Latest news

23.01.2019 - Change

HRB 156611: Explicat Pharma GmbH, Hohenbrunn, District of Munich, Georg Born Knorr, Str. 4, 85662 Hohenbrunn. The Shareholders ’ Meeting of January 16, 2019 resolved to amend § § 6 (assignment of shares) and 8 (succession) of the Articles of Association.

22.12.2014 - Change

Business address new:
Georg-Knorr-Str. 4, 85662 Hohenbrunn [formerly: Weidenstr. 22, 85662 Hohenbrunn]

10.05.2012 - Change

Capital new:
125.000,00 EUR [formerly: 25.000,00 EUR]
Show more publications

Job offers

Jobs (1)
Published
Hauswirtschafterin / Köchin (w/m/d) in Teilzeit mit 25 Std. / Woche (Hauswirtschafter/in)
14.07.2026

Details

Former addresses
Weidenstr. 22, Hohenbrunn
Legal form
Limited Liability Company
Industry codes
Manufacture of basic pharmaceutical products and pharmaceutical preparations, Manufacture of pharmaceutical preparations
Website
explicat.com
VAT ID
DE241485170
Capital
125.000 €
Founding date
1 April 2005
Last change
17 September 2026

Financial ratios

More financial data

SCHUFA report

Schufa report example
Example report

  • Creditworthiness, default rate and credit limit recommendation

  • Business figures and bank details

  • Shareholders and capital

Order SCHUFA report now

Register documents

Original documents submitted to the commercial register for Explicat Pharma GmbH

Latest trade register documents

Current Trade Register Excerpt

Add to cart

Social contract from 16.01.2019

Add to cart

Protocol and decision from 16.01.2019

Add to cart

Registration report from 16.01.2019

Add to cart

Shareholder list from 10.05.2012

Add to cart

All current Register documents with excerpts

Add to cart

Annual reports

Annual report 2024 from 13.02.2026

Add to cart

Annual report 2023 from 15.01.2025

Add to cart

Annual report 2022 from 24.01.2024

Add to cart

Annual report 2021 from 16.01.2023

Add to cart

Annual report 2020 from 26.01.2022

Add to cart

Current annual reports (5)

Add to cart

Annual report 2019 from 01.12.2020

Add to cart

Annual report 2018 from 19.02.2020

Add to cart

Annual report 2017 from 14.02.2019

Add to cart

Annual report 2016 from 08.01.2018

Add to cart

Annual report 2015 from 23.01.2017

Add to cart

All annual reports (10)

Add to cart

News

Credit rating change based on new credit limit
Credit rating change based on new rating
The annual report 2025 is available
The annual report 2024 is available

Turnover and Employees

Exclusive for Premium Members

Questions about this company?

AI Assistant

Get answers about finances, owners and authorized representatives – based on available company data, with source references.

Similar Companies

Similarity score
Dr. Niedermaier Pharma GmbH
78%
CSO Pharma Consulting GmbH
78%
PSI CRO Deutschland GmbH
76%
Zytocare Herstellbetriebs GmbH
74%
APEX Gesellschaft für angewandte Pharmakologie und experimentelle Pharmakotherapie mbH
73%
Intercell Pharma GmbH
71%
MEDPROJECT PHARMA Entwicklungs- und Vertriebsgesellschaft mbH
68%
Dr. Niedermaier Pharma GmbH
68%
dh Pharma Solutions GmbH
63%
Lyomark Pharma GmbH
61%
Chatbot

ChatbotBeta

  • Get instant, accurate answers

  • Supported by official documents

  • Reliable information from authorized sources

Our language models are powerful, but check important information.

News about Explicat Pharma GmbH

Receive the latest news and important information, including management changes, credit rating changes and shareholder changes. Stay up to date by leaving your email address and following the company.
  • Monitoring tool for customers, suppliers and business partners
  • Receive an e-mail alert when something changes
  • Changes of shareholders

Create company report

Which information about the company Explicat Pharma GmbH shall be included?

CompanyHouse does not guarantee the timeliness, completeness, quality, reliability or the error-freeness of the data. If you have any questions or comments, please contact our Customer service.